Stories
Uncategorized
Americans Eligible for $4.5 Million Cough Medicine Settlement: Here’s Who Qualifies
A nationwide class-action lawsuit settlement could bring payments to consumers who purchased Robitussin cough medicine products that were falsely marketed as “non-drowsy.” The $4.5 million agreement, reached with manufacturer Haleon, resolves allegations that the products contained an active ingredient known to cause drowsiness, despite claims on the packaging. Newsweek reached out to Haleon for comment […]
Read More